379 Matching Annotations
  1. Mar 2017
    1. Peritoneal Cancer
    2. Fallopian Tube
    3. Recurrent Epithelial Ovarian
    4. paclitaxel and topotecan
    5. paclitaxel and cisplatin
    6. Carcinoma of the Cervix
    7. interferon alfa
    8. Metastatic Renal Cell Carcinoma
    9. Glioblastoma
    10. paclitaxel
    11. carboplatin
    12. Non-Squamous Non–Small Cell Lung Cancer
    13. oxaliplatin
    14. fluoropyrimidine
    15. irinotecan
    16. 5-fluorouracil
    17. Metastatic Colorectal Cancer
    18. bevacizumab
    1. glucocorticoids
    2. Microscopic Polyangiitis
    3. methotrexate
    4. cyclophosphamide
    5. fludarabine
    6. Wegener's Granulomatosis
    7. Granulomatosis with Polyangiitis
    8. Rheumatoid Arthritis
    9. Chronic Lymphocytic Leukemia
    10. Non–Hodgkin's Lymphoma (NHL)
    11. rituximab
    1. Metastatic Gastric Cancer
    2. Metastatic Breast Cancer
    3. carboplatin
    4. docetaxel
    5. paclitaxel
    6. cyclophosphamide
    7. doxorubicin
    8. HER2 overexpressing node positive
    9. Breast Cancer
    10. trastuzumab
  2. Feb 2017
    1. hypertension
    2. renal failure
    3. glomerulonephritis
    4. nephrotic syndrome
    5. renal dysfunction
    6. estrogen therapy
    7. corticosteroid
    8. hepatic cirrhosis
    9. congestive heart failure
    10. edema
    11. hydroflumenthiazide